Record the gaze
Records how visual attention is distributed during the activities shown on screen.
For professionals: SNS organises a child’s gaze and supports clinical reading in neurodevelopmental screening, ages 2 to 5. Interpretation stays clinical. In development — not a validated diagnostic.
SmartNeuroScreen (SNS) supports neurodevelopmental screening in early childhood with eye tracking. During on-screen activities, SNS records where a child looks and brings path, time in each area and indicators into a record that is easier to read clinically. The professional decides whether further investigation is needed. Gaze is only one part: the child’s history and daily life count too. The tool is in development and is not a validated diagnostic.
Records how visual attention is distributed during the activities shown on screen.
Brings together gaze path, time in each area and activity indicators in a record that is easier to read clinically.
Provides complementary information for a qualified professional’s analysis.
Eye tracking helps answer three questions: where attention concentrates, how the gaze moves through a scene and how long it stays in each area.
Conceptual example: the geometric shapes are not part of the real protocol, and trajectories, intensities and proportions are fictional. They do not represent a child, age norms, research results or referral criteria. One measure describes one activity; interpretation must consider the child.
A visual experience. In the initial stage, the tool focuses on eye tracking while the child watches visual stimuli on screen.
Designed for children from age 2, with an initial focus on ages 2 to 5. Extending to other ages is planned for later phases; the initial range is not a definitive maximum age.
The range is a project development target, not a validated normative range.
Background literature on eye movements and methods. It does not constitute validation of this product.
Families, professionals, educators and administrators have different questions. The tool’s role has to be clear to each of them.
Learn about a way to record a child’s visual attention and discuss the results with a professional. Developmental concerns should be taken to a professional, with or without screening.
Get your questions answeredReview gaze records and indicators and integrate them with developmental history and assessment. Interpretation and referral decisions remain with the professional.
Understand the recordsA proposal that may support screening projects and dialogue between school, family and health professionals. Any school use requires defined conditions, guardian participation and professional interpretation. Gaze recording does not measure school performance.
Talk about the school contextExplore research, pilot projects and future use in developmental services. Network adoption requires adequate evidence, conditions of use and a follow-up pathway after screening.
Talk about a partnershipThe tool is in development. Ways of using it and partnership options are discussed with the team as the project advances.
SmartNeuroCompany is Júlia, Luciana and Rodrigo. SmartNeuroScreen brings together clinical experience, research and software development.
Neuropsychologist with a master’s in Neurosciences from PUCRS, now a PhD candidate in Neurosciences. Founder of SmartNeuroScreen, she links clinical practice to the questions that guide the project.
Neuropsychologist with a PhD in Medicine and Health Sciences from PUCRS and postdoctoral training in Paediatrics and Child Health. She contributes to the project’s scientific and educational work.
Responsible for platform development and technical structure: system implementation, data organisation and report building.
What the tool does and how to understand its role.
For children from age 2, with an initial focus on ages 2 to 5. Extension is planned for future phases; there is no definitive maximum age.
No. The initial phase focuses on eye tracking during visual activities and includes no questionnaires.
It is in development. Contact SmartNeuroCompany to learn about the current stage, available features and options for a demonstration or collaboration.
Professionals, researchers and institutions can write to smartneuroscreen@gmail.com. Children’s data is not needed for the first contact.
Professionals, schools, families and institutions can write to learn about SNS. We reply by email. This conversation does not book a screening: the tool is in development.